| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.11e-05 | 14 | 90 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | glycolipid binding | 7.00e-05 | 49 | 90 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.47e-04 | 23 | 90 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 2.97e-04 | 29 | 90 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 2.97e-04 | 29 | 90 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | actin binding | 3.09e-04 | 479 | 90 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 4.79e-04 | 34 | 90 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 7.34e-04 | 90 | 90 | 4 | GO:0008028 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 2.92e-05 | 14 | 91 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.64e-05 | 15 | 91 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.64e-05 | 15 | 91 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 3.64e-05 | 15 | 91 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.64e-05 | 15 | 91 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 4.46e-05 | 16 | 91 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 5.40e-05 | 17 | 91 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 5.40e-05 | 17 | 91 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 5.40e-05 | 17 | 91 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 6.46e-05 | 18 | 91 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 8.97e-05 | 20 | 91 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.04e-04 | 21 | 91 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.04e-04 | 21 | 91 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.04e-04 | 21 | 91 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.20e-04 | 22 | 91 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.38e-04 | 23 | 91 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.38e-04 | 23 | 91 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.57e-04 | 24 | 91 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.57e-04 | 24 | 91 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.57e-04 | 24 | 91 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.78e-04 | 25 | 91 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.78e-04 | 25 | 91 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.80e-04 | 187 | 91 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.25e-04 | 27 | 91 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 2.51e-04 | 28 | 91 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | liver development | 2.74e-04 | 202 | 91 | 6 | GO:0001889 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.79e-04 | 29 | 91 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 2.96e-04 | 205 | 91 | 6 | GO:0061008 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 3.41e-04 | 31 | 91 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 3.76e-04 | 32 | 91 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 3.76e-04 | 32 | 91 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 3.76e-04 | 32 | 91 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 4.12e-04 | 33 | 91 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 4.12e-04 | 33 | 91 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 4.50e-04 | 34 | 91 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 4.50e-04 | 34 | 91 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 4.91e-04 | 35 | 91 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 6.27e-04 | 38 | 91 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 6.77e-04 | 39 | 91 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 7.29e-04 | 40 | 91 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 7.84e-04 | 41 | 91 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 8.42e-04 | 42 | 91 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | bone resorption | 9.69e-04 | 99 | 91 | 4 | GO:0045453 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.03e-03 | 45 | 91 | 3 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.10e-03 | 46 | 91 | 3 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.10e-03 | 46 | 91 | 3 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.17e-03 | 47 | 91 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.17e-03 | 47 | 91 | 3 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.17e-03 | 47 | 91 | 3 | GO:0034104 | |
| GeneOntologyBiologicalProcess | receptor internalization | 1.28e-03 | 182 | 91 | 5 | GO:0031623 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.32e-03 | 49 | 91 | 3 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.32e-03 | 49 | 91 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.40e-03 | 50 | 91 | 3 | GO:0002834 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 4.29e-05 | 16 | 91 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | ciliary membrane | 6.91e-05 | 98 | 91 | 5 | GO:0060170 | |
| MousePheno | decreased carbon dioxide production | 1.55e-05 | 31 | 69 | 4 | MP:0008964 | |
| Domain | L_dom-like | LRRC8E FBXL16 LRFN2 INSRR PKD1 LRCH4 TMOD2 PHLPP1 LRRC40 CHADL LRRTM1 LRRK1 LRRN4 CPN2 | 4.69e-10 | 328 | 89 | 14 | IPR032675 |
| Domain | Leu-rich_rpt_typical-subtyp | LRRC8E LRFN2 PKD1 LRCH4 PHLPP1 LRRC40 CHADL LRRTM1 LRRK1 LRRN4 CPN2 | 7.80e-10 | 177 | 89 | 11 | IPR003591 |
| Domain | LRR_TYP | LRRC8E LRFN2 PKD1 LRCH4 PHLPP1 LRRC40 CHADL LRRTM1 LRRK1 LRRN4 CPN2 | 7.80e-10 | 177 | 89 | 11 | SM00369 |
| Domain | - | LRRC8E FBXL16 LRFN2 PKD1 LRCH4 TMOD2 PHLPP1 LRRC40 CHADL LRRTM1 LRRK1 LRRN4 CPN2 | 3.90e-09 | 321 | 89 | 13 | 3.80.10.10 |
| Domain | Leu-rich_rpt | LRRC8E FBXL16 LRFN2 PKD1 LRCH4 PHLPP1 LRRC40 CHADL LRRTM1 LRRK1 LRRN4 CPN2 | 6.01e-09 | 271 | 89 | 12 | IPR001611 |
| Domain | LRR_8 | LRRC8E LRFN2 PKD1 LRCH4 PHLPP1 LRRC40 CHADL LRRTM1 LRRN4 CPN2 | 8.67e-09 | 171 | 89 | 10 | PF13855 |
| Domain | LRR | LRRC8E LRFN2 PKD1 LRCH4 PHLPP1 LRRC40 CHADL LRRTM1 LRRK1 CPN2 | 4.05e-08 | 201 | 89 | 10 | PS51450 |
| Domain | LRR_1 | LRRC8E LRFN2 LRCH4 PHLPP1 LRRC40 CHADL LRRTM1 LRRK1 LRRN4 CPN2 | 9.07e-08 | 219 | 89 | 10 | PF00560 |
| Domain | - | 1.09e-05 | 222 | 89 | 8 | 1.25.10.10 | |
| Domain | ARM-type_fold | 3.41e-05 | 339 | 89 | 9 | IPR016024 | |
| Domain | ARM-like | 4.42e-05 | 270 | 89 | 8 | IPR011989 | |
| Domain | Cys-rich_flank_reg_C | 7.01e-05 | 90 | 89 | 5 | IPR000483 | |
| Domain | LRRCT | 7.01e-05 | 90 | 89 | 5 | SM00082 | |
| Domain | LRRNT | 1.05e-04 | 98 | 89 | 5 | IPR000372 | |
| Domain | LRRNT | 1.05e-04 | 98 | 89 | 5 | SM00013 | |
| Domain | PH_dom-like | 9.66e-04 | 426 | 89 | 8 | IPR011993 | |
| Domain | Helicase_C | 1.71e-03 | 107 | 89 | 4 | PF00271 | |
| Domain | HELICc | 1.71e-03 | 107 | 89 | 4 | SM00490 | |
| Domain | Helicase_C | 1.77e-03 | 108 | 89 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.83e-03 | 109 | 89 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.83e-03 | 109 | 89 | 4 | PS51192 | |
| Domain | DEXDc | 1.83e-03 | 109 | 89 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.89e-03 | 110 | 89 | 4 | IPR014001 | |
| Domain | - | 2.58e-03 | 16 | 89 | 2 | 1.10.1070.11 | |
| Domain | Laminin_N | 2.58e-03 | 16 | 89 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 2.58e-03 | 16 | 89 | 2 | PS51117 | |
| Domain | Laminin_N | 2.58e-03 | 16 | 89 | 2 | PF00055 | |
| Domain | PI3Kc | 2.58e-03 | 16 | 89 | 2 | SM00146 | |
| Domain | LamNT | 2.58e-03 | 16 | 89 | 2 | SM00136 | |
| Domain | - | 2.64e-03 | 391 | 89 | 7 | 2.30.29.30 | |
| Domain | DUF1605 | 2.91e-03 | 17 | 89 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 2.91e-03 | 17 | 89 | 2 | PF07717 | |
| Domain | PI3/4_kinase_cat_dom | 3.27e-03 | 18 | 89 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.27e-03 | 18 | 89 | 2 | PF00454 | |
| Domain | HA2 | 3.27e-03 | 18 | 89 | 2 | SM00847 | |
| Domain | PI3_4_KINASE_3 | 3.27e-03 | 18 | 89 | 2 | PS50290 | |
| Domain | HA2 | 3.27e-03 | 18 | 89 | 2 | PF04408 | |
| Domain | PI3_4_KINASE_1 | 3.27e-03 | 18 | 89 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.27e-03 | 18 | 89 | 2 | PS00916 | |
| Domain | Helicase-assoc_dom | 3.27e-03 | 18 | 89 | 2 | IPR007502 | |
| Domain | DH_1 | 3.38e-03 | 63 | 89 | 3 | PS00741 | |
| Domain | RhoGEF | 4.19e-03 | 68 | 89 | 3 | SM00325 | |
| Domain | - | 4.30e-03 | 663 | 89 | 9 | 2.60.40.10 | |
| Domain | RhoGEF | 4.55e-03 | 70 | 89 | 3 | PF00621 | |
| Domain | DH_2 | 4.55e-03 | 70 | 89 | 3 | PS50010 | |
| Domain | DH-domain | 4.73e-03 | 71 | 89 | 3 | IPR000219 | |
| Domain | - | 4.73e-03 | 71 | 89 | 3 | 1.20.900.10 | |
| Domain | Ig_2 | 5.11e-03 | 73 | 89 | 3 | PF13895 | |
| Domain | IGc2 | 5.33e-03 | 235 | 89 | 5 | SM00408 | |
| Domain | Ig_sub2 | 5.33e-03 | 235 | 89 | 5 | IPR003598 | |
| Domain | Ig-like_fold | 6.44e-03 | 706 | 89 | 9 | IPR013783 | |
| Domain | IQ | 6.83e-03 | 81 | 89 | 3 | SM00015 | |
| Domain | EGF_LAM_2 | 8.96e-03 | 30 | 89 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 8.96e-03 | 30 | 89 | 2 | PS01248 | |
| Domain | IQ_motif_EF-hand-BS | 9.12e-03 | 90 | 89 | 3 | IPR000048 | |
| Pubmed | 3.31e-07 | 54 | 92 | 5 | 8482578 | ||
| Pubmed | Proteome-wide characterization of N-glycosylation events by diagonal chromatography. | 1.97e-06 | 77 | 92 | 5 | 16944957 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 5.03e-06 | 13 | 92 | 3 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 5.03e-06 | 13 | 92 | 3 | 1985902 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 10964771 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 5.03e-06 | 13 | 92 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 5.03e-06 | 13 | 92 | 3 | 16638824 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 20044046 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 32150576 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 22469976 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 5.03e-06 | 13 | 92 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 5.03e-06 | 13 | 92 | 3 | 28035001 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 5.03e-06 | 13 | 92 | 3 | 12832451 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 5.03e-06 | 13 | 92 | 3 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 5.03e-06 | 13 | 92 | 3 | 21670291 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 5.03e-06 | 13 | 92 | 3 | 23935487 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 2702644 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 8380065 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 1279194 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 15331748 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 5.03e-06 | 13 | 92 | 3 | 22406619 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 7628460 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 25724769 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 26374765 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 5.03e-06 | 13 | 92 | 3 | 25972571 | |
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 5.03e-06 | 13 | 92 | 3 | 22092845 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 11801635 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 28913658 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 19008452 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 5.03e-06 | 13 | 92 | 3 | 15220458 | |
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 5.03e-06 | 13 | 92 | 3 | 8500759 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 5.03e-06 | 13 | 92 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 5.03e-06 | 13 | 92 | 3 | 23800882 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 15207636 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 19285068 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 21760897 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 5.03e-06 | 13 | 92 | 3 | 1326665 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 21081647 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 5.03e-06 | 13 | 92 | 3 | 39168268 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 11483763 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 8402684 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 2164599 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 16619040 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 5.03e-06 | 13 | 92 | 3 | 8209741 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 5.03e-06 | 13 | 92 | 3 | 21949477 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 29396368 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 26219866 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 18003729 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 26284027 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 2133556 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 32521208 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 5.03e-06 | 13 | 92 | 3 | 33352461 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 19406938 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 38381498 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 20739537 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 5.03e-06 | 13 | 92 | 3 | 29967450 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 5.03e-06 | 13 | 92 | 3 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 5.03e-06 | 13 | 92 | 3 | 27695943 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 20404914 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 16680193 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 26911181 | ||
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 1653760 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 5.03e-06 | 13 | 92 | 3 | 32027621 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 5.03e-06 | 13 | 92 | 3 | 27777319 | |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 18848945 | ||
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 37531413 | ||
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 23780386 | ||
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 28567513 | ||
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 8207827 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 6.38e-06 | 14 | 92 | 3 | 34666041 | |
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 19700760 | ||
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 34619794 | ||
| Pubmed | Expression patterns of CD66a and CD117 in the mouse submandibular gland. | 6.38e-06 | 14 | 92 | 3 | 25498293 | |
| Pubmed | Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling. | 6.38e-06 | 14 | 92 | 3 | 29746166 | |
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 9212243 | ||
| Pubmed | CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo. | 6.38e-06 | 14 | 92 | 3 | 27572314 | |
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 1648219 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 6.38e-06 | 14 | 92 | 3 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 6.38e-06 | 14 | 92 | 3 | 32209360 | |
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 11994468 | ||
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 11850617 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 6.38e-06 | 14 | 92 | 3 | 27161904 | |
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 6.38e-06 | 14 | 92 | 3 | 26196244 | |
| Pubmed | 6.38e-06 | 14 | 92 | 3 | 8896983 | ||
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 4.82e-06 | 11 | 57 | 3 | 1315 | |
| GeneFamily | Laminin subunits | 6.32e-04 | 12 | 57 | 2 | 626 | |
| GeneFamily | DEAH-box helicases | 1.14e-03 | 16 | 57 | 2 | 500 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.18e-03 | 66 | 57 | 3 | 722 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.60e-08 | 156 | 92 | 7 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.60e-08 | 156 | 92 | 7 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 1.77e-07 | 197 | 92 | 7 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 1.77e-07 | 197 | 92 | 7 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-06 | 162 | 92 | 6 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-06 | 165 | 92 | 6 | 50a8513d8d2630861499393a7f102b35366bad37 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.12e-06 | 194 | 92 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus_(TRN))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.95e-06 | 57 | 92 | 4 | ade0457d85acaf87fcbeb6ac0d81525bb4a96950 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus_(TRN))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.95e-06 | 57 | 92 | 4 | 0e92c8af66bfdf9de6410c82f404b65b1424e09c | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Six3-Pvalb_(Thalamic_reticular_nucleus_(TRN))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.95e-06 | 57 | 92 | 4 | 00083b7c710affa6e24ed495ed46ec6fcea8b676 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Lmo2_(eccentric_SPN,_dSPN-like_markers)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.84e-06 | 59 | 92 | 4 | dbb61f03be7d2c7fa7d32c743fcff2dc91ae0d75 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Otof-Lmo2_(eccentric_SPN,_dSPN-like_markers)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.84e-06 | 59 | 92 | 4 | e6cbbe1a4961066cae8f8c03a838f37e60a5391a | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.07e-06 | 132 | 92 | 5 | fe87cb22e13e17df29ad43327f1aa71361907582 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.07e-06 | 132 | 92 | 5 | 82f312a561d9fdd2ebc2c25926dfc2b333ff0a4f | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-05 | 142 | 92 | 5 | 94e277f038f4006d99ff50222b0f5cf89bc3d46d | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 162 | 92 | 5 | 860ebf2390b4ad86475ad54717cbefcf61cd3b2a | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 162 | 92 | 5 | 14e9f8aaba308619eb9da90796c336e76cedac1f | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 165 | 92 | 5 | 4f95c2fe5ab4416c736fe0d1936695a2b26777eb | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 165 | 92 | 5 | 3e913b49a868fdd5589200ae3e9be77c0938ba14 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-05 | 167 | 92 | 5 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-05 | 167 | 92 | 5 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-05 | 167 | 92 | 5 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 167 | 92 | 5 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-05 | 167 | 92 | 5 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 168 | 92 | 5 | 2201ae834b53cbdc085f8f02607fa5b5bd911268 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.98e-05 | 173 | 92 | 5 | ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.98e-05 | 173 | 92 | 5 | 3725525b99a6011eda2ff5459b4fd2e1eab1f090 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.98e-05 | 173 | 92 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 174 | 92 | 5 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-05 | 174 | 92 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-05 | 178 | 92 | 5 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-05 | 178 | 92 | 5 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 178 | 92 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 89 | 92 | 4 | e7d9498a1a3aa974fdd68b394c3eaff8e35c9727 | |
| ToppCell | P28-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.21e-05 | 186 | 92 | 5 | a38f84f478798951c8798c8e90e4897c729cf630 | |
| ToppCell | P28-Endothelial-unknown_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.21e-05 | 186 | 92 | 5 | dde38decf368775694bbeae38a3ff084017c34ab | |
| ToppCell | droplet-Skin-nan-21m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 187 | 92 | 5 | 38d7b19fde6811f5fbf548b2464486b197476dc6 | |
| ToppCell | droplet-Skin-nan-21m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 187 | 92 | 5 | ea33a5bd60b7f5f6d5b07a7f06a5a56395943641 | |
| ToppCell | droplet-Skin-nan-21m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 187 | 92 | 5 | 1dbc2c0ab85033e5de776bbfdb73ebd3a50d2cc6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.42e-05 | 188 | 92 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 4.42e-05 | 188 | 92 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.42e-05 | 188 | 92 | 5 | e82104f71bcdab7392fdb076dc3560255964fd9e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 189 | 92 | 5 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.65e-05 | 190 | 92 | 5 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 191 | 92 | 5 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 192 | 92 | 5 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 5.01e-05 | 193 | 92 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Activated_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 5.14e-05 | 194 | 92 | 5 | 219056d4ad256cda73208b8c570bbf689219df83 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.26e-05 | 195 | 92 | 5 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.39e-05 | 196 | 92 | 5 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-05 | 198 | 92 | 5 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.66e-05 | 198 | 92 | 5 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-05 | 199 | 92 | 5 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-05 | 199 | 92 | 5 | aca81a879ef9c196bd1885eff4c63ffe6c9682b7 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.93e-05 | 200 | 92 | 5 | a4c41509ca936e137230a6ae548c90f18a566d12 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.20e-04 | 122 | 92 | 4 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-04 | 124 | 92 | 4 | d88bce8a4f023d5b617b2e8e372a94bd1248d20d | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 126 | 92 | 4 | 65c7c0e4cfb5ac58d80b4034d42e9f662116e0d3 | |
| ToppCell | Bronchial-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 126 | 92 | 4 | b6482ef18e6d9e12ba4810ce7845f9f991cb95bc | |
| ToppCell | Bronchial-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 126 | 92 | 4 | 12f3d0f60db462f2a9799b3a06005bc871670760 | |
| ToppCell | TCGA-Mesothelium|World / Sample_Type by Project: Shred V9 | 1.53e-04 | 130 | 92 | 4 | 3ef1733eb57e2a9a3298ce0d65401f19e2084df1 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.62e-04 | 132 | 92 | 4 | 4e37400ae7375e6986f060234c373194603346f8 | |
| ToppCell | E15.5-Hematopoietic-Erythroid-enucleate_erythrocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-04 | 143 | 92 | 4 | e4207ff9e8248813356631631bbf31a63f23ad3c | |
| ToppCell | E15.5-Hematopoietic-Erythroid|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-04 | 143 | 92 | 4 | 15a7b93c381ef0f455f99f3abf4b2b9454d35bc4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 149 | 92 | 4 | 61d84838a841ed2d6b8c5f86d423a4e6b3dcc9cb | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 2.99e-04 | 155 | 92 | 4 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-04 | 155 | 92 | 4 | d10cf5e922dbd3ca46660404da5aca43f181fc19 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 157 | 92 | 4 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-04 | 157 | 92 | 4 | 904cd98ae85ed6459e0663f077ac462842bf12df | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 157 | 92 | 4 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 158 | 92 | 4 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 158 | 92 | 4 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.29e-04 | 159 | 92 | 4 | b9d34b9ed8db798f5ea93c44b469cae499403cb8 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.45e-04 | 161 | 92 | 4 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.54e-04 | 162 | 92 | 4 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.54e-04 | 162 | 92 | 4 | 2f19539c455d1e5d514725845234c7547020e6ad | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-04 | 164 | 92 | 4 | a784f47f67a5eda84d58ad7d9400e3978edbb487 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-04 | 164 | 92 | 4 | 1a1795969673232191425dde84ab24ee6a98143f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-04 | 164 | 92 | 4 | 8f074940afdbda88a4b697a7ddc687e09a4b818b | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 164 | 92 | 4 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | ICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, Lineage and Cell Type | 3.97e-04 | 167 | 92 | 4 | 5b7b731944d888591279ef6167b3ae8cab3f6886 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-04 | 167 | 92 | 4 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.97e-04 | 167 | 92 | 4 | ecdbfde870a2a44c44b9dd65a8737afc6fbf816c | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-04 | 167 | 92 | 4 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 168 | 92 | 4 | e870d2e69316406f45112ed0bf324b24f902a99e | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.06e-04 | 168 | 92 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 168 | 92 | 4 | 403aba73a0f9ffb32252288d075fad8a588ca440 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.15e-04 | 169 | 92 | 4 | 29db25e7c5f31d98a08a35d7ec5ade203242bc50 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.15e-04 | 169 | 92 | 4 | 0cece9b2bb1f58e465c20ec8735a4fc3c1021f03 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.15e-04 | 169 | 92 | 4 | b1611e61f635f8f9b87250e026ad30999cbee041 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.15e-04 | 169 | 92 | 4 | 6937c46b119d4ce382fc8c2fa5925ede5ae89c81 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 4.15e-04 | 169 | 92 | 4 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-04 | 170 | 92 | 4 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.24e-04 | 170 | 92 | 4 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 171 | 92 | 4 | 2e7cc311005958af52f39ca6c310c85b43a85aaf | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 4.34e-04 | 171 | 92 | 4 | 78491478ba65bad45238fe114f5251b2adea323d | |
| ToppCell | COVID-19-lung-RBC|lung / Disease (COVID-19 only), tissue and cell type | 4.34e-04 | 171 | 92 | 4 | 0e8d63c8fbccdda4f1ef00de00667a50464b104b | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.34e-04 | 171 | 92 | 4 | a4d6b0f57eead11b01153688b06b2a45a3b488f2 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 171 | 92 | 4 | 4b599f953c8e5b947b2c8bbbf7fe6f9dc388e336 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.43e-04 | 172 | 92 | 4 | 9a256db817c1af1802203cc88a55d608fb328c63 | |
| Computational | Neighborhood of CDKN1C | 1.87e-04 | 27 | 45 | 3 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 3.12e-04 | 32 | 45 | 3 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 4.09e-04 | 35 | 45 | 3 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 7.02e-04 | 42 | 45 | 3 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 9.18e-04 | 46 | 45 | 3 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.10e-03 | 49 | 45 | 3 | GNF2_KISS1 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 3 in blood serum | 8.01e-06 | 2 | 84 | 2 | OBA_2043058 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 4 in blood serum | 8.01e-06 | 2 | 84 | 2 | OBA_2043059 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0801907 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 1.67e-04 | 7 | 84 | 2 | EFO_0801906 | |
| Disease | Graves Disease | 2.85e-04 | 9 | 84 | 2 | C0018213 | |
| Disease | cup-to-disc ratio measurement, optic cup area measurement, optic disc area measurement | 3.55e-04 | 10 | 84 | 2 | EFO_0006937, EFO_0006939, EFO_0006940 | |
| Disease | MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K | 7.13e-04 | 14 | 84 | 2 | C1836373 | |
| Disease | alpha-Dystroglycanopathies | 7.13e-04 | 14 | 84 | 2 | C2936406 | |
| Disease | Muscle eye brain disease | 7.13e-04 | 14 | 84 | 2 | C0457133 | |
| Disease | Fukuyama Type Congenital Muscular Dystrophy | 7.13e-04 | 14 | 84 | 2 | C0410174 | |
| Disease | Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1 | 7.13e-04 | 14 | 84 | 2 | C4284790 | |
| Disease | Walker-Warburg congenital muscular dystrophy | 8.21e-04 | 15 | 84 | 2 | C0265221 | |
| Disease | revision of total joint arthroplasty, aseptic loosening | 9.36e-04 | 16 | 84 | 2 | EFO_0010725, EFO_0020974 | |
| Disease | cD177 antigen measurement | 1.19e-03 | 18 | 84 | 2 | EFO_0021866 | |
| Disease | lymphocyte:monocyte ratio | 1.41e-03 | 288 | 84 | 5 | EFO_0600088 | |
| Disease | Varicose veins | 2.28e-03 | 193 | 84 | 4 | HP_0002619 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GHDLDLYIPIFTLLQ | 266 | Q8N1M1 | |
| PGQLYQDLQNLLHDL | 746 | O15013 | |
| QPAAALLHIYLKNLS | 126 | Q9N2J8 | |
| KLYLGSNNLTALHPA | 341 | P22792 | |
| LGPLLYHFENLANEL | 341 | Q8N4J0 | |
| AIDLNGYVLLHPNLK | 551 | Q9NY47 | |
| QLLYLSLLSGLHGQE | 26 | O43505 | |
| QLAELLFALPAYHTL | 201 | Q17RM4 | |
| DNTIPLLYGILAHFL | 101 | Q96NB1 | |
| LALEQLYALGALNHL | 791 | O60231 | |
| LIFLPGLAHIQQLYD | 871 | Q7Z478 | |
| LYTLLLPGLELHGAQ | 151 | A6H8M9 | |
| LLLPSLGYNGAILAH | 1171 | P78312 | |
| LLHKLGDNAYPFTLQ | 101 | P36575 | |
| NLYHSLPPLLSQLAL | 266 | Q9H2T7 | |
| VHLYLQPGTSNLELL | 171 | A0A1B0GVH7 | |
| ALPLAHLLQTQNQGY | 141 | Q8WV74 | |
| HKVAGQLLPLAYNLL | 306 | Q9NWY4 | |
| HVLLVDGFSQPYLLL | 661 | Q9Y5E7 | |
| LNPALGNLTALTYLN | 106 | O75427 | |
| LLIDYGQLSAPQLHL | 291 | Q9GZQ6 | |
| PVYGHGSQSLINLLL | 211 | Q9H8M7 | |
| LAIAHYSQPTDLQLL | 161 | Q9NXD2 | |
| ALPVANDSYLLPHLL | 981 | Q38SD2 | |
| PHNLSGLLGLSLRYN | 61 | Q86UE6 | |
| YNKLQALAPDLFHGL | 146 | Q86UE6 | |
| LNLQGFQLLLLHPSA | 26 | A7E2Y1 | |
| PVLYHAGTVLLNSLL | 186 | P55058 | |
| NGLSDLYHPIQILAD | 161 | P00480 | |
| GLYLHNLLGLATLPE | 246 | P47871 | |
| LQHLALSYNALEALP | 701 | Q6NSJ5 | |
| TLHPPNLLLFYNLSQ | 111 | Q96KJ4 | |
| GSDNDYLILNLHIPG | 481 | A8MWY0 | |
| PLQHLDTLLDGTYKQ | 691 | Q3SYG4 | |
| LTLDPHNVDYLLGLF | 276 | P05186 | |
| DLLLQYDCLALNLHG | 296 | Q01638 | |
| PAESLGQLLLFHLNS | 706 | O14981 | |
| VLHGYAAQQLPSLLK | 66 | Q5T6F0 | |
| ELASYPLDQHLIQLG | 2126 | A8TX70 | |
| YLSLQELQGQDPTHL | 536 | P14784 | |
| HDEYLQLLNLLQPTL | 111 | Q9BYX4 | |
| NYLGHFLLTNLLLDT | 151 | Q8N5I4 | |
| QLAEGLLSHYLPDLQ | 51 | Q9UL45 | |
| NAASFPGNLHLVLVL | 16 | P10911 | |
| GYNLEPQLQHSLGLV | 361 | P14616 | |
| LLCFALPGLLHAQQA | 6 | Q13751 | |
| ATLNLAHNALVYLPA | 161 | Q6NUI6 | |
| VLLLVHNLPQNLAGY | 51 | Q00888 | |
| NLGQVLLHCLYDSDP | 136 | Q96ER3 | |
| ILLGLSYVAPHLNNL | 306 | Q14CX5 | |
| QVGLLAVPLLAAYLH | 16 | Q5EB52 | |
| LSETNLLPQSLQHYL | 611 | Q9Y2J2 | |
| NNDISSLPYSLGNLH | 321 | Q9H9A6 | |
| PAGLHTLDLSYNQLA | 121 | Q8WUT4 | |
| PAAGLHLQLNYTLLD | 2916 | P98161 | |
| VLLLVHNLPQNLAGY | 51 | Q16557 | |
| APLHYLAPLLSNLSQ | 171 | Q9BTY7 | |
| NNLPGSLLHTAAYLI | 51 | Q8N328 | |
| LDPQSYSLIHQLLSA | 246 | Q15406 | |
| LLPNLAELSLQAYHV | 266 | Q8N461 | |
| SGHYLGDLLLQQAEL | 606 | P0C091 | |
| SLELDHLNFINNPYL | 906 | P35499 | |
| LVALNYQTDDLPLHL | 1811 | Q9P212 | |
| QELLQHSLPLGSYLL | 211 | A1L390 | |
| PALALLSDYVLHNSN | 461 | Q13200 | |
| LGLLNLIGKYSQHPD | 511 | A1A5C7 | |
| GLFPAILNLASNAHI | 21 | P25391 | |
| YHPLGSLSNLEETLN | 151 | Q9H5K3 | |
| YSEQSPLSHDLILNL | 46 | Q9BSU1 | |
| PLLSHILLEHNYALA | 1291 | O15047 | |
| NVDFSHLLGFLPLNL | 411 | Q9UPG8 | |
| DLLHNSIYPLAAINP | 1156 | Q14865 | |
| LSHKGNAIYNLLPDI | 1156 | Q15021 | |
| PLDQHIHSLLLYALF | 141 | Q96B21 | |
| LLALYQGHLANFPDI | 521 | Q96RF0 | |
| QEAYLEALSHLQSPL | 721 | O00329 | |
| GQSLELLHLLFLYQP | 441 | Q96DC7 | |
| LIPQSDNLYGLKLDH | 201 | Q86WI1 | |
| YSPGLQQLAHLLLEA | 1296 | Q86YV5 | |
| HNPGLALLHLLLLYG | 101 | Q5TGU0 | |
| APQHFYAALLQLGLK | 1001 | Q8TEQ8 | |
| LNLSNNHLGDFPLAV | 696 | O60346 | |
| LYPLGHSLILIVLNN | 276 | Q9NYW2 | |
| EALLQTGPHLLLQTY | 116 | Q6UX68 | |
| GQLSQSAHLALQLPY | 486 | Q8TB96 | |
| SAHLALQLPYNVLGL | 491 | Q8TB96 | |
| TLGLLGSLYHALLQP | 241 | Q9BT76 | |
| VLLLVHNLPQNLAGY | 51 | Q15238 | |
| DHYLIPNALLELALL | 541 | Q5SRH9 | |
| SHDLLYQEFLPLLPN | 771 | Q9Y4A5 | |
| LYDLAAVLGVHNLLN | 131 | Q9NZR1 | |
| GQLLPQHYLNDLDSA | 1496 | Q7Z3T8 | |
| LALNIAYGVLPQLLA | 336 | Q9BZW5 | |
| LEDLDLSYNNLHGLP | 151 | Q9ULH4 | |
| LLAAILHLGNLQYEA | 321 | Q13402 |